Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bacterial colangitis: therapeutic features]

M. Russo1, S. Carmellino, G. Russo

  • 1Cattedra di Malattie Infettive, Istituto di Malattie Infettive, Seconda Universita degli Studi di Napoli, Italy.

Le Infezioni in Medicina
|May 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Rezafungin and catheter-related candidemia: a new player in a high-stakes game.

Le infezioni in medicina·2026
Same journal

Effectiveness and Safety Profile of BIC/TAF/FTC in People living with HIV Switched from Other Antiretroviral Regimens: A Real-Life Retrospective Cohort Analysis.

Le infezioni in medicina·2026
Same journal

Insights into parvovirus B19 clinical and virological dynamics among blood donors.

Le infezioni in medicina·2026
Same journal

When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship.

Le infezioni in medicina·2026
Same journal

Fragility of Immunisation and Water Systems in Gaza: Infectious Disease Risks in a Conflict-Affected Setting.

Le infezioni in medicina·2026
Same journal

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
See all related articles

Effective cholangitis treatment requires addressing biliary obstruction and using appropriate antibiotics. Advances in endoscopy and antibiotics improve patient outcomes, with specific regimens targeting common bacteria like E. coli and Klebsiella.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Cholangitis, characterized by biliary obstruction and bacterial infection, has seen improved prognoses due to advancements in diagnosis and treatment.
  • Key factors influencing antimicrobial choice include bacterial sensitivities, biliary excretion, and the presence of obstruction or bacteremia.

Purpose of the Study:

  • To review current strategies for diagnosing and treating cholangitis.
  • To discuss optimal antibiotic selection and administration for cholangitis, considering various clinical scenarios.

Main Methods:

  • Literature review of studies on cholangitis diagnosis and treatment.
  • Analysis of antibiotic efficacy, resistance patterns, and clinical outcomes.

Main Results:

Related Experiment Videos

  • Successful cholangitis management necessitates relieving biliary obstruction and administering targeted antibiotics.
  • Initial empirical therapy should cover E. coli and Klebsiella; coverage for Enterococcus, Pseudomonas, and anaerobes remains debated.
  • Piperacillin-tazobactam, cephalosporins (cefamandole, cefoxitin, cefoperazone, cefepime), and aminoglycosides (with reduced nephrotoxicity risk) are discussed for treatment.

Conclusions:

  • Prompt endoscopic drainage is crucial for suppurative cholangitis.
  • Antibiotic prophylaxis, particularly with piperacillin, is recommended for preventing cholangitis after ERCP in high-risk patients.
  • Maintenance antibiotic therapy can be beneficial for recurrent cholangitis in compromised biliary tracts.